3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Leukemia
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Adenocarcinoma Of Esophagus
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Multiple Myeloma
1
Liposarcoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Paclitaxel
57
Carboplatin
51
Bevacizumab
41
Taxes
28
liposomal doxorubicin
21
Gemcitabine
19
Immunoglobulin G
17
Disulfides
17
pembrolizumab
15
Topotecan
12
rucaparib
10
Cyclophosphamide
9
Cisplatin
9
Docetaxel
8
olaparib
7
Doxorubicin
7
pazopanib
6
mirvetuximab soravtansine
6
cediranib
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
sargramostim
4
niraparib
4
Surgical Procedures, Operative
4
Drug Therapy
4
Cytoreduction Surgical Procedures
4
Albumin-Bound Paclitaxel
4
veliparib
3
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Fallopian Tube Neoplasms
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
No trials found.